We are live on ! Find out more
EDIT icon

Editas Medicine

116 hedge funds and large institutions have $698M invested in Editas Medicine in 2017 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 37 increasing their positions, 26 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 16

42% more capital invested

Capital invested by funds: $490M → $698M (+$207M)

42% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 26

5% more funds holding

Funds holding: 110116 (+6)

1.64% less ownership

Funds ownership: 70.65%69.01% (-1.6%)

30% less call options, than puts

Call options by funds: $6.76M | Put options by funds: $9.71M

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

Holders
116
Holders Change
+6
Holders Change %
+5.45%
% of All Funds
2.89%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
24
Increased
37
Reduced
26
Closed
16
Calls
$6.76M
Puts
$9.71M
Net Calls
-$2.94M
Net Calls Change
-$6.9M
Name Holding Trade Value Shares
Change
Change in
Stake
Victory Capital Management
51
Victory Capital Management
Texas
$956K -$38.8K -2,040 -5%
RhumbLine Advisers
52
RhumbLine Advisers
Massachusetts
$802K +$13.7K +721 +2%
TD Asset Management
53
TD Asset Management
Ontario, Canada
$691K -$55.2K -2,900 -9%
GCP
54
GSA Capital Partners
United Kingdom
$667K +$529K +27,800 New
Manulife (Manufacturers Life Insurance)
55
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$636K -$6.62K -348 -1%
ProShare Advisors
56
ProShare Advisors
Maryland
$619K +$29.6K +1,556 +6%
NIT
57
NumerixS Investment Technologies
British Columbia, Canada
$610K +$158K +8,290 +48%
State of Wisconsin Investment Board
58
State of Wisconsin Investment Board
Wisconsin
$600K
CIM
59
CIM Investment Management
Pennsylvania
$597K
Group One Trading
60
Group One Trading
Illinois
$586K -$629K -33,060 -58%
MLICM
61
Metropolitan Life Insurance Company (MetLife)
New York
$576K
AIG
62
American International Group
New York
$544K +$32.3K +1,695 +8%
Nisa Investment Advisors
63
Nisa Investment Advisors
Missouri
$533K -$1.07M -56,000 -72%
PPA
64
Parametric Portfolio Associates
Washington
$510K -$228 -12 -0.1%
MWVC
65
Morgens Waterfall Vintiadis & Co
New York
$480K +$381K +20,000 New
TI
66
Trexquant Investment
Connecticut
$470K +$372K +19,556 New
Jane Street
67
Jane Street
New York
$453K +$359K +18,871 New
NFA
68
Nationwide Fund Advisors
Ohio
$448K -$10.4K -547 -3%
Arrowstreet Capital
69
Arrowstreet Capital
Massachusetts
$423K +$11.4K +600 +4%
VOYA Investment Management
70
VOYA Investment Management
Georgia
$369K
Royal Bank of Canada
71
Royal Bank of Canada
Ontario, Canada
$333K +$85.5K +4,494 +48%
SCA
72
Secor Capital Advisors
New York
$326K -$1.67M -87,612 -87%
MSAM
73
Moloney Securities Asset Management
Missouri
$319K +$253K +13,285 New
Barclays
74
Barclays
United Kingdom
$307K +$239K +12,546 +4,882%
State Board of Administration of Florida Retirement System
75
State Board of Administration of Florida Retirement System
Florida
$273K

EDIT Hedge Fund Activity: Q3 2017 in Review

116 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q3 2017, worth a combined $698M — up 42% from $490M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new EDIT positions and 16 closed out — a net gain of 8 holders — while 37 added to existing stakes and 26 trimmed.

The largest buyer was State Street, adding an estimated $25M. The largest seller was Flagship Pioneering, cutting an estimated $32.4M.

  • 116 institutional investors held Editas Medicine (EDIT) as of Q3 2017, up from 110 in Q2 2017.
  • Funds reported $698M of Editas Medicine stock for Q3 2017, up 42% quarter-over-quarter.
  • 24 funds opened new Editas Medicine positions in Q3 2017 and 16 closed out, a net change of +8 holders.
  • The largest Editas Medicine buyer in Q3 2017 was State Street, an estimated $25M added.
  • The largest Editas Medicine seller in Q3 2017 was Flagship Pioneering, an estimated $32.4M sold.

Based on aggregated 13F filings for Q3 2017.